- Home
- ATNM vs BCOW Comparison
ATNM vs BCOW Comparison
Compare ATNM & BCOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- BCOW
- Stock Information
- Founded
- ATNM 2000
- BCOW 1895
- Country
- ATNM United States
- BCOW United States
- Employees
- ATNM N/A
- BCOW N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- BCOW Finance: Consumer Services
- Sector
- ATNM Health Care
- BCOW Finance
- Exchange
- ATNM Nasdaq
- BCOW Nasdaq
- Market Cap
- ATNM 56.5M
- BCOW 56.1M
- IPO Year
- ATNM N/A
- BCOW 2019
- Fundamental
- Price
- ATNM $1.73
- BCOW $10.05
- Analyst Decision
- ATNM Strong Buy
- BCOW
- Analyst Count
- ATNM 5
- BCOW 0
- Target Price
- ATNM $14.20
- BCOW N/A
- AVG Volume (30 Days)
- ATNM 285.8K
- BCOW 6.3K
- Earning Date
- ATNM 10-31-2024
- BCOW 11-07-2024
- Dividend Yield
- ATNM N/A
- BCOW N/A
- EPS Growth
- ATNM N/A
- BCOW N/A
- EPS
- ATNM N/A
- BCOW N/A
- Revenue
- ATNM $81,000.00
- BCOW $9,896,000.00
- Revenue This Year
- ATNM $186.10
- BCOW N/A
- Revenue Next Year
- ATNM $19,248.94
- BCOW N/A
- P/E Ratio
- ATNM N/A
- BCOW N/A
- Revenue Growth
- ATNM 80.00
- BCOW N/A
- 52 Week Low
- ATNM $1.33
- BCOW $6.00
- 52 Week High
- ATNM $10.24
- BCOW $10.45
- Technical
- Relative Strength Index (RSI)
- ATNM 41.48
- BCOW 66.31
- Support Level
- ATNM $1.48
- BCOW $9.97
- Resistance Level
- ATNM $1.80
- BCOW $10.10
- Average True Range (ATR)
- ATNM 0.12
- BCOW 0.07
- MACD
- ATNM 0.04
- BCOW -0.02
- Stochastic Oscillator
- ATNM 54.44
- BCOW 16.67
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About BCOW 1895 Bancorp of Wisconsin Inc. (MD)
1895 Bancorp of Wisconsin Inc acts as the mutual holding company reorganization of PyraMax Bank, FSB, to become the savings and loan holding company of PyraMax Bank, FSB. Its business consists predominantly of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one-to-four family residential real estate loans, commercial real estate loans, commercial loans, and consumer loans.